Login
Register
Reset Password
Publish & Distribute
Publishing Solutions
Distribution Solutions
Subjects
Architecture and Design
Arts
Business and Economics
Chemistry
Classical and Ancient Near Eastern Studies
Computer Sciences
Cultural Studies
Engineering
General Interest
Geosciences
History
Industrial Chemistry
Jewish Studies
Law
Library and Information Science, Book Studies
Life Sciences
Linguistics and Semiotics
Literary Studies
Materials Sciences
Mathematics
Medicine
Music
Pharmacy
Philosophy
Physics
Social Sciences
Sports and Recreation
Theology and Religion
Publications
Journals
Books
Proceedings
Publishers
Blog
Contact
Search
EUR
USD
GBP
English
English
Deutsch
Polski
Español
Français
Italiano
Cart
Home
Journals
Forum of Clinical Oncology
Volume 12 (2021): Issue 1 (May 2021)
Open Access
Antidiabetic drugs and the risk of cancer: beneficial, neutral, or detrimental?
Taoreed Adegoke Azeez
Taoreed Adegoke Azeez
,
Sharif Adeniyi Folorunso
Sharif Adeniyi Folorunso
,
Chinedu Eguzozie
Chinedu Eguzozie
and
Adeleke Adedapo Adegboyega
Adeleke Adedapo Adegboyega
| Aug 09, 2021
Forum of Clinical Oncology
Volume 12 (2021): Issue 1 (May 2021)
About this article
Previous Article
Next Article
Abstract
Article
References
Authors
Articles in this Issue
Preview
PDF
Cite
Share
Article Category:
Research Article
Published Online:
Aug 09, 2021
Page range:
74 - 81
Received:
Aug 04, 2020
Accepted:
Sep 21, 2020
DOI:
https://doi.org/10.2478/fco-2021-0014
Keywords
antidiabetic drugs
,
diabetes
,
cancer
© 2021 Taoreed Adegoke Azeez et al., published by Sciendo
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Taoreed Adegoke Azeez
Endocrinology, Metabolism and Diabetes Unit, Department of Medicine, University College Hospital
Ibadan, Nigeria
Sharif Adeniyi Folorunso
Department of Radiation Oncology, University College Hospital
Ibadan, Nigeria
Chinedu Eguzozie
Endocrinology, Metabolism and Diabetes Unit, Department of Medicine, University College Hospital
Ibadan, Nigeria
Adeleke Adedapo Adegboyega
Department of Clinical Pharmacology, University College Hospital
Ibadan, Nigeria